With a market cap of $50.5 billion, Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a global healthcare solutions ...

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced the execution of a five-year ...

How to Order TRIESENCE TRIESENCE (J-Code 3300) is available to healthcare providers directly through major pharmaceutical wholesale distributors, including Cencora, Cardinal Health, and McKesson.

The stock's rival, Cencora, Inc. (COR), has underperformed ... As of writing, MCK is trading below the mean price target of $677.80. On the date of publication, Sohini Mondal did not have ...

Good morning and welcome everyone to the Information Services Group Fourth Quarter 2024 Conference Call. This call is being recorded and a replay will be available on ISG's website within 24 hours.

Valued at a market cap of $80.4 billion, McKesson Corporation (MCK) is a leading healthcare services and information technology company. The Irving, Texas-based company operates through four segments: ...

In a recent 8-K filing with the Securities and Exchange Commission, Cencora, Inc., a Delaware-based company in the wholesale drug industry and a prominent player in Healthcare Providers & Services ...

In a recent 8-K filing with the Securities and Exchange Commission, Cencora, Inc., a Delaware-based company in the wholesale drug industry and a prominent player in Healthcare Providers & Services ...

It has been about a month since the last earnings report for Cencora (COR). Shares have added about 3.1% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

Fisher Asset Management LLC boosted its stake in shares of Cencora, Inc. (NYSE:COR – Free Report) by 17.7% during the 4th quarter, according to its most recent 13F filing with the SEC.